How important is serum β-hCG in the management of ectopic pregnancy?

Sandya M. Renukesh, Lavanya Rai, Shripad Hebbar

Abstract


Background: Objective: To investigate whether serum β-hCG levels may influence presentation & management of ectopic pregnancy.

Methods: A total of 176 women diagnosed with ectopic pregnancy were divided into 4 groups based on initial serum β-hCG values; group 1 - <1000 mIU/ml, group 2 - 1001-3000 mIU/mL, group 3 - 3001-5000 mIU/ml, group 4 - >5000 mIU/ml. The clinical presentations, ultrasound findings, mode of management & success of medical management in relation to serum β-hCG values were recorded.

Results: There were no significant correlations between Serum β-hCG values and ultrasound findings. Ectopic pregnancies with values less than 1000 mIU/ml could also present with rupture, requiring surgical management. A falling trend on Day 4 serum β-hCG was a good predictor of successful medical management. Out of the 28 patients managed medically, 21 (75%) had resolution of ectopic pregnancy, remaining 7, who did not show a subsequent decline on the fourth day, required either repeat dosage or surgical intervention. The study also revealed a positive correlation between initial β-hCG values and site of ectopic gestation. More than 80% (16/19) of patients with cornual ectopic had initial values greater than 10,000 mIU/ml.

Conclusions: Serum β-hCG is a complementary and a useful tool in diagnosis & management of ectopic pregnancy.

Keywords


Serum β-hCG, Ectopic pregnancy

Full Text:

PDF

References


Nguyen Q, Kapitz M, Downes K, Silva C. Are human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? Am J Obstet Gynecol. 2010;202:630.e1-5.

Skubisz MM, Li J, Wallace EM, Tong S. Decline in β-hCG levels between days 0 and 4 after single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study. BJOG. 2011;118:1665-8.

Dilbaz S, Caliskan E, Dilbaz B, Degrimenci O, Haberal A. Predictors of methotrexate treatment failure in ectopic pregnancy. J Reprod Med. 2006;51:87-93.

Sagiv R, Debby A, Feit H, Cohen-Sacher B, Keidar R, Golan A. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy. Int J Gynecol Obstet. 2012;116:101-4.

Farquhar CM. Ectopic pregnancy. Lancet. 2005;366:583-91.

Kirk E, Bourne T. The nonsurgical management of ectopic pregnancy. Curr Opin Obstet Gynecol. 2006;18:587-93.

Agostini A, Blanc K, Ronda I, Romain F, Capelle M, Blanc B. Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy. Fertil Steril. 2007;88:504-6.

Celik E, Turkcuoglu I, Karaer A, Kinci P, Eraslan S. Assessment of early decline in the percentage of β-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success. J Turkish- German Gynecol Assoc. 2013;14:125-9.

Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med. 2000;343:1325-9.

Bouyer J, Coste J, Fernandez H, Pouly JL, Job-Spira N. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002;17(12):3224-30.